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Abstract
Background: Visceral leishmaniasis has emerged as an important opportunistic disease among patients infected with HIV-1.
Both HIV-1 and the protozoan parasite Leishmania can productively infect cells of the macrophage-dendritic cell lineage.
Methodology/Principal Findings: Here we demonstrate that Leishmania infantum amastigotes increase HIV-1 production
when human primary dendritic cells (DCs) are cocultured together with autologous CD4
+ T cells. Interestingly, the
promastigote form of the parasite does not modulate virus replication. Moreover, we report that amastigotes promote virus
replication in both cell types. Our results indicate that this process is due to secretion of parasite-induced soluble factors by
DCs. Luminex micro-beads array system analyses indicate that Leishmania infantum amastigotes induce a higher secretion
of several cytokines (i.e. IL-1a, IL-2, IL-6, IL-10 and TNF-a) and chemokines (i.e. MIP-1a, MIP-1b and RANTES) in these cells.
Studies conducted with pentoxifylline and neutralizing antibodies revealed that the Leishmania-dependent augmentation
in HIV-1 replication is due to a higher secretion of IL-6 and TNF-a.
Conclusions/Significance: Altogether these findings suggest that the presence of Leishmania within DC/T-cell conjugates
leads to an enhancement of virus production and demonstrate that HIV-1 and Leishmania can establish complex
interactions in such a cellular microenvironment.
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Introduction
Leishmaniasis is today recognized as one of the world’s most
important parasitic diseases, threatening 350 million people in 88
countries [1]. At least 20 Leishmania species can induce various
clinical manifestations better known as leishmaniasis. Infection by
these trypanosomatid protozoan parasites may lead to a variety of
symptoms, ranging from simple, self-healing skin ulcers to a severe,
life-threatening visceral disease caused by the Leishmania donovani
complex, including Leishmania infantum. One of the most neglected
diseases, visceral leishmaniasis (VL) is the most severe form of
leishmaniasis, characterized by fevers, suppressed immunity and
hepatosplenomegaly.
Of particular interest, VL has also emerged as an important
opportunistic infection in individuals also infected with human
immunodeficiency virus type-1 (HIV-1). Indeed, the outbreak of
the HIV-1/AIDS pandemic during the past two decades has
dramatically modified the natural history of infection by Leishmania
in co-infected patients. According to the World Health Organi-
zation (WHO), HIV-1/Leishmania co-infection has been reported
in 34 countries in several regions of the globe such as Africa, Asia,
Europe, and South America. The increase in the number of cases
of co-infection arises from the overlap between regions of active
HIV-1 transmission, mostly cities and urbanized areas, and the
regions in which Leishmania is endemic. VL is prevalent in HIV-1/
Leishmania co-infected individuals and is known to promote not
only the development of AIDS-defining illness conditions but also
its clinical progression, therefore diminishing the life expectancy of
HIV-1-infected subjects. For example, in dually infected patients
from southern Europe, all of the isolates were Leishmania infantum
[1,2]. Furthermore, HIV-1 infection increases the risk of
developing VL in endemic areas, enhances the probability of
relapse and is also associated with a poorer anti-parasitic drug
response [1,2]. It has been proposed that HIV-1 and Leishmania act
in a deadly synergy. HIV-1/Leishmania co-infection exerts
cumulative deficiency of the cellular immune response since both
agents harm similar immune resources, such as macrophages and
dendritic cells, for their reciprocal benefit [3–5].
Dendritic cells (DCs) are versatile antigen-presenting cells,
recognizing and capturing invading pathogens and establishing a
vital bridge between innate and adaptive immunity. DCs also play
a key role in HIV-1 infection and dissemination. Indeed, it has
been reported that HIV-1 is efficiently transferred from immature
DCs to CD4
+ T cells via different routes [6–9]. For example, after
www.plosntds.org 1 May 2009 | Volume 3 | Issue 5 | e441the cells capture and bind HIV-1, a rapid transfer (i.e. early
transfer or trans infection) occurs when the virus on the surface of
immature DCs or located within endosomal compartments is
transported to the DC/T-cell synapse and transmitted directly to
CD4
+ T cells. This event is followed by a second phase (i.e. late
transfer or cis infection) that is dependent on productive virus
infection of immature DCs and on the eventual transfer of progeny
viruses to CD4
+ T cells. It has been proposed that after virus
capture or uptake, immature DCs (iDCs) located in submucosal
tissues migrate to lymphoid tissues and become mature DCs
(mDCs) [10–12], which can potently present nominal antigens to
CD4
+ T cells in lymphoid tissues.
Although the possible multifaceted interactions between HIV-1
and Leishmania have been studied in macrophages [13–15], there is
still very little information on the consequences of infection of DCs
with these two microorganisms. In macrophages, Leishmania
increases both HIV-1 gene transcription and release of progeny
virus through production of proinflammatory cytokines. On the
other hand, some studies have suggested that DCs can be infected
by either Leishmania promastigotes or amastigotes [16,17]. It has
also been reported that competition between HIV-1 and Leishmania
amastigotes for DC-SIGN binding has an impact on the HIV-1
life cycle when DCs were first exposed to the parasite before
inoculation with HIV-1 [18].
Proinflammatory cytokines play an important role in both
innate and adaptive immune responses against viruses and
intracellular pathogens. Interestingly, TNF-a has been reported
to stimulate HIV-1 replication in the promonocytic U1 cell line
through NF-kB activation and subsequent trans-activation of the
viral regulatory elements [19]. In addition, IL-6 has been reported
to stimulate HIV-1 replication in macrophages again via a NF-kB-
mediated signal transduction pathway [20–22]. An increased
production of IL-6 and TNF-a has been detected in Leishmania-
infected macrophages [23,24]. Thus, in the case of HIV-1/
Leishmania co-infected patients, it is likely that HIV-1 uses a part of
the Leishmania-mediated cytokine network to its own advantage.
In the present work, we investigated the influence of Leishmania
infection on the biology of HIV-1 in physiologically relevant
human DCs. We demonstrate here for the first time that Leishmania
infantum amastigotes promote HIV-1 replication in both DCs and
autologous CD4
+ T cells when these two cell subpopulations are
cultured together. The mechanism responsible for this up-
regulatory effect is linked with secretion of parasite-induced
soluble factors by DCs.
Materials and Methods
Ethics statement
Human primary DCs were generated from monocytes obtained
from the blood of healthy donors, in accordance with the
guidelines of the Bioethics Committee of the Centre Hospitalier
de l’Universite ´ Laval Research Center. A written consent was
obtained from all blood donors.
Reagents
Recombinant human interleukin-2 (rhIL-2), efavirenz (EFV)
and azidothymidine (AZT) were obtained from the NIH AIDS
Repository Reagent Program (Germantown, MD). Interferon-
gamma (IFN-c) and IL-4 were purchased from R&D Systems
(Minneapolis, MN), whereas granulocyte macrophage–colony
stimulating factor (GM-CSF) was a generous gift from Cangene
(Winnipeg, MB). Lipopolysaccharide (LPS) and phytohemagglu-
tinin-L (PHA-L) were purchased from Sigma (St-Louis, MO). The
culture medium consisted of RPMI-1640 supplemented with 10%
foetal bovine serum (FBS), penicillin G (100 U/mL), streptomycin
(100 U/mL) and glutamine (2 mM), which were all purchased
from Wisent (St-Bruno, QC), and primocine (Amaxa Biosystems,
Gaithersburg, MD).
Isolation and culture of cells
In brief, CD14
+ cells (i.e. monocytes) were isolated from
peripheral blood mononuclear cells, using a monocyte-positive
selection kit according to the manufacturer’s instructions (CD14-
positive selection kit; StemCell Technologies Inc., Vancouver, BC)
and cultured in six-well plates (10
6 cells/ml). Immature DCs
(iDCs) were generated from these purified monocytes by a
treatment with GM-CSF (1,000 U/ml) and IL-4 (200 U/ml) for
7 days. The maturation of iDCs was induced on the fifth day by
culturing them for 48 h with the above-described cytokines
supplemented with IFN-c (1,000 U/ml) and LPS (100 ng/ml).
The final phenotype of iDCs and mature monocyte-derived DCs
(mDCs) was monitored by flow cytometry (data not shown). For
example, iDCs expressed HLA-DR, CD86, DC-SIGN, CD1a and
low levels of CD14, whereas mDCs expressed CD83 and high
levels of ICAM-1, HLA-DR, and CD86 but lower levels of DC-
SIGN and CD14 compared to iDCs (data not shown). iDCs were
considered effectively differentiated based on the loss of CD14 and
acquisition of CD1a and DC-SIGN (data not shown). Autologous
CD4
+ T cells were isolated with a negative selection kit (StemCell
Technologies) and activated (2610
6 cells/ml) with the mitogenic
agent PHA-L (1 mg/ml) and rhIL-2 (30 U/ml) for 48 h prior to
their use.
Viral preparations
Viruses were produced upon transient calcium phosphate
transfection of 293T cells either with pNL4-3Balenv, an R5-tropic
infectious molecular clone of HIV-1 [25], or pNLBalHSA-IRES
(see below for more details). Virus stocks were normalized for
virion content by using a sensitive in-house, double-antibody
sandwich enzyme-linked immunosorbent assay specific for the
Author Summary
Visceral leishmaniasis (VL) is a potentially deadly parasitic
disease afflicting millions worldwide. Although itself an
important infectious illness, VL has also emerged as an
opportunistic disease among patients infected with HIV-1.
This is partly due to the increasing overlap between urban
regions of high HIV-1 transmission and areas where
Leishmania is endemic. Furthermore, VL increases the
development and clinical progression of AIDS-related
diseases. Conversely, HIV-1-infected individuals are at
greater risk of developing VL or suffering relapse. Finally,
HIV-1 and Leishmania can both productively infect cells of
the macrophage-dendritic cell lineage, resulting in a
cumulative deficiency of the immune response. We
therefore studied the effect of Leishmania infantum on
HIV-1 production when dendritic cells (DCs) are cocultured
with autologous CD4
+ T cells. We show that amastigotes
promote virus replication in both DCs and lymphocytes,
due to a parasite-mediated production of soluble factors
by DCs. Micro-beads array analyses indicate that Leish-
mania infantum amastigotes infection induces a higher
secretion of several cytokines in these cells, and use of
specific neutralizing antibodies revealed that the Leish-
mania-induced increase in HIV-1 replication is due to IL-6
and TNF-a. These findings suggest that Leishmania’s
presence within DC/T-cell conjugates leads to an en-
hanced HIV-1 production.
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single freeze-thaw cycle before being used in subsequent
experiments. The pNLBalHSA-IRES molecular construct has
been described previously [27] and was obtained by replacing the
eGFP gene in the NLENG1-IRES vector (NL4-3 backbone) with
the coding sequence for mouse heat stable antigen (HSA) and
replacing the X4-tropic env gene of NL4-3 with that of the R5-
using env gene of NL4-3Balenv.
Culture of Leishmania infantum parasites
The Leishmania infantum strain MHOM/MA/67/ITMAP-263
was maintained at 27uC by a weekly passage in RPMI-1640
supplemented with 10% FBS, buffered with 25 mM HEPES and
2 mM NaHCO3, containing 5 mg/ml haemin and antibiotics.
Axenic Leishmania infantum amastigotes were differentiated in vitro
from stationary-phase promastigotes. The culture and mainte-
nance of axenic amastigotes have been described previously [28].
These amastigotes showed morphological, biochemical and
biological characteristics similar to those of amastigotes isolated
in vivo [28].
Virus transmission assays
DCs (both iDCs and mDCs) were first pulsed with NL4-3Balenv
(10 ng of p24/10
5 cells) for 60 min at 37uC and unbound virus
was eliminated by extensive washes with phosphate-buffered saline
(PBS). Next, DCs were exposed to Leishmania infantum promasti-
gotes or axenic amastigotes at a parasite/cell ratio of 10:1 for up to
4 h and free parasites were washed out with warm PBS. Cells were
then incubated with activated CD4
+ T cells at a 1:3 ratio
(DCs:CD4
+ T cells). Viral production was assayed by measuring
Figure 1. Leishmania infantum amastigotes enhance HIV-1 replication in cocultures consisting of DCs and autologous CD4
+ T cells.
First, iDCs (A) and mDCs (B) were pulsed for 60 min with NL4-3Balenv and either left unexposed (Control) or exposed to live Leishmania infantum
promastigotes (Live Li-PRO), live Leishmania infantum amastigotes (Live Li-AMA), or killed Leishmania infantum amastigotes (Killed Li-AMA). Next, cells
were cocultured with autologous CD4
+ T cells and virus production was estimated by measuring p24 levels in the culture supernatants at the
indicated time points. Virus production at day 2 following initiation of the coculture is depicted in the small inserts (upper left part of each panel).
Data shown represent the means6SEM of triplicate samples and are representative of six independent experiments. Asterisks denote statistically
significant differences from the cells infected with HIV-1 only (**, P,0.01).
doi:10.1371/journal.pntd.0000441.g001
Leishmania Modulates HIV-1 Replication
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experiments, DCs were treated either with EFV (50 nM) or AZT
(10 mM) for 30 min before pulsing with virions.
In virus transfer experiments aimed at evaluating the percentage
of virus-infected CD4
+ T cells, we used NLBalHSA-IRES virus.
Three days after initiation of the coculture, cells were stained
either with an isotype-matched irrelevant control antibody or anti-
CD3 (American Type Culture Collection, Manassas, VA) followed
by an FITC-conjugated goat anti-mouse IgG (Jackson ImmunoR-
esearch Laboratories, West Grove, PA) and biotin-conjugated
anti-HSA followed by R-PE-labelled streptavidin (the latter two
from BD Pharmingen, San Diego, CA). Stained cells were fixed
with 2% paraformaldehyde for 30 min at 4uC and then analyzed
by flow cytometry (Epics ELITE ESP; Coulter Electronics,
Burlington, VA).
In some HIV-1 transfer studies, permeable cell inserts with
polycarbonate membranes (Transwell, Corning Inc., Lowell, MA)
(pore size: 1 mm) were used to separate DCs and CD4
+ T cells.
iDCs were exposed (or not) to parasites for 3 h, washed with PBS
and transferred into a culture plate. Next, activated autologous
CD4
+ T cells were pulsed with HIV-1 for 2 h, washed with PBS
and either cocultured directly with iDCs or transferred into
permeable cell inserts and cocultured with iDCs for 3 days. Virus
production was assessed by estimating the p24 content.
Acute virus infection of iDCs and CD4
+ T cells
De novo virus production in iDCs was monitored by incubating
the cells for 1 h at 37uC with NL4-3Balenv (10 ng of p24/10
5 cells).
After three washes with PBS, the cells were maintained in
complete culture medium without autologous CD4
+ T cells. Virus
production was estimated by quantifying the p24 content in cell-
free culture supernatants. In some studies, autologous activated
CD4
+ T cells were inoculated with NL4-3Balenv for 2 h and excess
virus washed off with PBS. Next, iDCs were either left untreated
or exposed to Leishmania infantum amastigotes for 3 h, washed, and
cocultured with HIV-1-exposed autologous CD4
+ T cells at a 1:3
ratio. Virus production was determined by measuring p24 levels in
the culture supernatants.
To analyze the effect of DC-derived soluble factors on viral
production in CD4
+ T cells, 0.22 mm-filtered culture supernatants
(Millipore, Billerica, MA) were used in parallel experiments.
Supernatants were harvested from unstimulated (control) or
amastigote-pulsed iDCs after 24 h of culture. Next, activated
autologous CD4
+ T cells were inoculated with NL4-3 Balenv for
2 h and excess virus was washed off with PBS. Infected CD4
+ T
cells were then incubated for 3 days with filtered supernatants
from DCs.
Cytokine multiplex assay and blocking studies
A commercial multiplex cytokine/chemokine assay that can
detect and quantify different cytokines and chemokines (i.e. IL-1a,
IL-2, IL-4, IL-6, IL-10, IL-12, IL-15, TNF-a, IFN-c, MIP-1a,
MIP-1b and RANTES) through the use of the Luminex 100
apparatus was purchased from Bio-Rad (Wilmington, DE). The
Luminex technology is a bead array cytometric analyzer designed
to study numerous analytes simultaneously by using spectrally
distinct beads in a single well of a microtiter plate, using very small
sample volumes (i.e. as little as 25 ml). Briefly, iDCs were either left
unexposed or exposed to Leishmania infantum amastigotes for 4 h
and free parasites were removed with warm PBS. Cell-free
supernatants were harvested from unstimulated (control) or
Leishmania-exposed iDCs after 24 h of culture. Quantification
was achieved by measuring concentrations of the studied
cytokines/chemokines in cell-free supernatants according to the
manufacturer’s instructions (Bio-Rad).
The TNF-a inhibitor pentoxifylline (PTX) (1-(59-oxohexyl)-3,7-
dimethylxanthine; Sigma-Aldrich; 100 mM final concentration),
neutralizing anti-TNF-a (R&D Systems; 500 ng/ml final concen-
tration) and neutralizing anti-IL-6 (R&D Systems; 10 mg/ml final
concentration) were added to the culture medium when initiating
virus transmission or during acute infection studies and then every
2 or 3 days with each medium change.
Statistical analysis
The statistical significance of the results was defined by
performing a one-way ANOVA analysis of variance with
Dunnett’s post-tests to compare treated versus untreated control
samples. All analyses were performed on raw data (i.e. p24
concentrations). P values lower than 0.05 were considered
statistically significant. InStat software (version 3.05; GraphPad
Software) was used for all analyses.
Results
Leishmania amastigotes enhances HIV-1 replication in
cocultures consisting of DCs and CD4
+ T cells
In an attempt to provide precious information on possible
relationships between Leishmania and HIV-1, we studied the effect
of Leishmania infantum on HIV-1 replication in the context of
cocultures constituted of DCs and autologous CD4
+ T cells. To
this end, both iDCs and mDCs were first pulsed with R5-tropic
virus and next exposed to Leishmania infantum amastigotes and
promastigotes. Thereafter, DCs were cocultured with autologous
CD4
+ T cells. A statistically significant enhancement of virus
replication was observed when iDCs were exposed to the
amastigote form of the parasite (Fig. 1A). Similar observations
were made when coculture experiments were performed with
mDCs (Fig. 1B). Since promastigotes and killed amastigotes have
not elicited any significant response in our experimental setup, all
further experiments were performed only with the most patho-
logically-relevant stage of the Leishmania parasite in the context of
HIV-1 infection, i.e. live amastigotes. The successful infection of
Figure 2. Virus replication is increased in both DCs and CD4
+ T
cells by Leishmania infantum amastigotes. First, iDCs were either
left untreated (Control) or treated with the antiviral agent EFV. Next,
cells were pulsed for 60 min with NL4-3Balenv and either left
unexposed or exposed to Leishmania infantum amastigotes (Li). Finally,
iDCs were cocultured with autologous CD4
+ T cells. Virus production
was estimated by measuring p24 levels in the culture supernatants at 4
days following initiation of the coculture. Data shown represent the
means6SEM of triplicate samples and are representative of five
independent experiments. Asterisks denote statistically significant
differences from the cells infected with HIV-1 only (**, P,0.01).
doi:10.1371/journal.pntd.0000441.g002
Leishmania Modulates HIV-1 Replication
www.plosntds.org 4 May 2009 | Volume 3 | Issue 5 | e441DCs with parasites was monitored using Leishmania infantum-based
reporter amastigotes as we described previously [15]. Laser-
scanning confocal microscopy was used to detect infection with
GFP-encoding parasites while a luminometer was used to measure
infection with luciferase-encoding amastigotes (data not shown).
Leishmania amastigotes increase virus production in
both DCs and CD4
+ T cells
To define the mechanism(s) by which the parasite can promote
HIV-1 replication in cocultures, iDCs were treated with the
antiretroviral drug EFV during the virus pulsing period. This
treatment will abrogate de novo virus production in iDCS without
affecting transfer of viruses located on their surface or within their
endosomal apparatus and the subsequent replication in CD4
+ T
cells. As expected, treatment with EFV reduces HIV-1 replication
in cocultured cells (Fig. 2) and completely abolished virus
production in iDCs cultured alone (data not shown). However,
the parasite-mediated increase in HIV-1 transmission was detected
in untreated and EFV-treated cells, therefore suggesting that
Leishmania amastigotes are promoting virus production in both
iDCs and CD4
+ T cells. Similar observations were made when
experiments were carried out with AZT (data not shown), which is
another potent reverse transcriptase inhibitor.
Next, to confirm that the parasite is affecting de novo virus
production in iDCs, these cells were first exposed to HIV-1 and
next to Leishmania promastigotes, and maintained in culture for 3
days before addition of autologous CD4
+ T cells. The rationale for
Figure 3. Leishmania infantum amastigotes enhance de novo virus production in DCs. (A) First, iDCs were pulsed for 60 min with NL4-
3Balenv and either left unexposed or exposed to Leishmania infantum amastigotes (Li). Next, cells were maintained in culture for 3 days before being
cocultured with autologous CD4
+ T cells. Virus production was estimated by measuring p24 levels in the culture supernatants at 4 days following
initiation of the coculture. Data shown represent the means6SEM of triplicate samples and are representative of five independent experiments.
Asterisks denote statistically significant differences from the cells infected with HIV-1 only (**, P,0.01). (B) First, iDCs were pulsed for 60 min with
NL4-3Balenv and either left unexposed or exposed to Leishmania infantum amastigotes (Li). Next, iDCs were maintained in culture in absence of
autologous CD4
+ T cells. Virus production was estimated by measuring p24 levels in the culture supernatants at the indicated time periods (i.e. 3, 6
and 9 days post-infection). Data shown represent the means6SEM of triplicate samples and are representative of five independent experiments.
Asterisks denote statistically significant differences from the cells infected with HIV-1 only (**, P,0.01).
doi:10.1371/journal.pntd.0000441.g003
Leishmania Modulates HIV-1 Replication
www.plosntds.org 5 May 2009 | Volume 3 | Issue 5 | e441this experimental setup is based on the previous report that
endosome-associated virions in DCs remain infectious for no more
than 2 days [9]. An increase in HIV-1 transfer was still seen in the
case of Leishmania-treated samples (Fig. 3A). To substantiate what
seems to be a more productive HIV-1 infection of iDCs in the
presence of Leishmania amastigotes, cells were pulsed with fully
competent virus in the absence or presence of amastigotes and
virus replication in iDCs cultured alone was evaluated over time.
Results depicted in Fig. 3B indicate that the parasite induces a
significant increase in de novo virus production in iDCs.
To provide additional information on how the presence of
amastigotes can modulate virus replication in a coculture system
made of iDCs and autologous CD4
+ T cells, we assessed whether
the observed increase in virus production is reflected by a
corresponding augmentation in the number of CD4
+ T cells
productively infected with HIV-1. To this end, coculture
experiments were carried out with NLBalHSA-IRES virus which,
upon acute infection of target cells, will produce all viral proteins
and also a cell surface reporter molecule (i.e. the murine heat-
stable antigen/HSA). Unlike most reporter viruses, fully infectious
NLBalHSA-IRES virions have no deletions in the env, vpr or nef
genes, and allow for the easy detection of productively infected
cells through the surface expression of the HSA molecule [27].
Pulsing iDCs with NLBalHSA-IRES virus followed by a coculture
step with autologous CD4
+ T cells for 3 days resulted in a
proportion of CD4
+ T cells productively infected with HIV-1
ranging from 7.8 to 9.9% as monitored by flow cytometry
measuring the relative percentage of HSA and CD3 double-
positive cells (Fig. 4). This percentage of virus-infected cells was not
affected when amastigotes were present during the pulsing step of
iDCs (i.e. percentages of HSA-expressing cells ranging from 8.1%
to 10.2%) (mean of 9.03% for cells infected with HIV-1 only
compared to 9.36% for cells inoculated with both HIV-1 and
Leishmania: P=0.73). This observation suggests that Leishmania
amastigotes do not affect the number of CD4
+ T cells which are
productively infected with HIV-1, at least at an early time period
following initiation of the coculture (i.e. 3 days). Therefore, it can
be proposed that Leishmania is most likely affecting virus production
in the CD4
+ T cell population by up-regulating virus gene
expression.
Leishmania-mediated enhancement in virus replication is
due to secretion of IL-6 and TNF-a by iDCs
To validate that HIV-1 production in CD4
+ T cells is enhanced
upon a coculture with Leishmania amastigotes-exposed iDCs, we
performed another set of experiments where autologous CD4
+ T
Figure 4. Frequency of virus-infected CD4
+ T cells in cocultures is not affected by Leishmania infantum amastigotes. First, iDCs were
pulsed for 60 min with NLBalHSA-IRES virus and either left unexposed or exposed to Leishmania infantum amastigotes (Li). Thereafter, iDCs were
cocultured with autologous CD4
+ T cells for 3 days. Finally, cells were stained with anti-CD3 and anti-HSA antibodies before being analyzed by flow
cytometry. Results depicted in the right and left panels are representative of a single experiment while the percentage of HSA-expressing cells in the
CD3-positive population is shown for three independent experiments (see table).
doi:10.1371/journal.pntd.0000441.g004
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either left untreated or inoculated with parasites. Results from
Fig. 5A demonstrate that viral replication in CD4
+ T cells is
augmented by a coculture step with Leishmania-loaded iDCs.
Moreover, we investigated whether a cell-to-cell contact is
necessary to achieve the observed phenomenon. To do so, we
used permeable cell supports with a membrane pore size of 1 mm,
which allows the crossing of virions and soluble factors but not that
of cells [29]. When iDCs were separated from CD4
+ T cells by a
permeable membrane, HIV-1 replication decreased in comparison
to the contact-favoured cocultured cells (Fig. 5A). However, virus
production was still augmented by Leishmania amastigotes even
when iDCs and CD4
+ T cells were not allowed to interact with
each other. Thus, these results suggest that a soluble factor(s)
secreted by Leishmania-pulsed DCs drives HIV-1 replication in
cocultured cells. Furthermore, when HIV-1-inoculated autologous
CD4
+ T cells were incubated with cell-free supernatants from
Leishmania-exposed iDCs, an increase in virus replication was seen
in CD4
+ T cells compared to those incubated with cell-free
supernatants from unexposed iDCs (Fig. 5B). Interestingly, heat-
inactivated supernatants from Leishmania-exposed iDCs had no
effect on viral replication in CD4
+ T cells. These observations
suggest that the Leishmania-directed augmentation in HIV-1
production in cocultures made of iDCs and autologous CD4
+ T
cells is due to a heat-sensitive soluble factor(s) secreted by iDCs.
In order to identify the Leishmania amastigote-induced soluble
factor(s) responsible for promoting virus replication in both DCs
and CD4
+ T cells, we quantified the levels of several cytokines and
Figure 5. Leishmania-dependent increase in virus production seen in cocultured cells is due to a soluble factor(s). (A) First, iDCs were
pulsed for 60 min with NL4-3Balenv and either left unexposed or exposed to Leishmania infantum amastigotes (Li). Next, iDCs were cocultured with
autologous CD4
+ T cells for 3 days either in contact (cell-to-cell contact) or in transwell conditions (no contact). Virus production was estimated by
measuring p24 levels in the culture supernatants at 4 days following initiation of the coculture. (B) iDCs were either left unexposed (control) or
exposed to Leishmania infantum amastigotes (Li) for 24 h. Next, cell-free supernatants were collected and either left untreated or subjected to a heat
treatment. Finally, autologous activated CD4
+ T cells were infected NL4-3Balenv and incubated for 3 days with untreated or heat-inactivated cell-free
supernatants from iDCs. Virus production was determined by measuring p24 levels in the culture supernatants. Data shown represent the
means6SEM of triplicate samples and are representative of five independent experiments. Asterisks denote statistically significant differences from
the cells infected with HIV-1 only (**, P,0.01).
doi:10.1371/journal.pntd.0000441.g005
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using the Multi Analyte Profiling bead array technology from
Luminex. Supernatants from Leishmania-pulsed iDCs display
higher levels of various cytokines and chemokines (i.e. IL-1a, IL-
6, IL-10, TNF-a, MIP-1a, MIP-1b and RANTES) than those
from untreated iDCs (Fig. 6). However, because of the strong
variability between the samples tested, only IL-6 and TNF-a
concentrations were increased in a statistically significant manner
by Leishmania infantum amastigotes.
It has been previously reported that treatment of HIV-1-
infected cells with IL-6 and TNF-a results in a significant
induction of virus gene expression in a variety of cell systems
directly through nuclear translocation of NF-kB [20–22,30].
Therefore, in an attempt to define the relative contribution of
these two proinflammatory cytokines to the Leishmania-mediated
stimulatory effect on virus production, transfer studies were
performed with PTX, a phosphodiesterase inhibitor that abolishes
TNF-a production [31], and blocking antibodies. Data from
Fig. 7A show a direct involvement of both IL-6 and TNF-a in the
Leishmania-dependent augmentation of HIV-1 replication in
cocultured cells. Interestingly, virus production was enhanced
upon addition of exogenous IL-6 and TNF-a to cocultured cells,
which further implicate both cytokines in the process. Similar
patterns were seen when iDCs were cultured alone in absence of
autologous CD4
+ T cells and treated with the listed reagents
(Fig. 7B). Altogether, these data indicate that Leishmania amasti-
gotes mediate a more important production of IL-6 and TNF-a by
iDCs, which in turn stimulates HIV-1 replication in both iDCs
and CD4
+ T cells.
Discussion
The multifaceted interplay between HIV-1 and Leishmania in
macrophages has been previously addressed [13,15]. However, the
macrophage is not the only cell type known to harbour both
pathogens. Indeed, previous studies have established that DCs are
also susceptible to HIV-1 and Leishmania infection (i.e. primarily by
amastigotes and marginally by promastigotes) [18,32,33]. Unfor-
tunately, there is a paucity of data on the consequences of DCs
infection with these two microorganisms. A previous study has
reported that Leishmania reduces HIV-1 capture and transfer by
DCs upon pre-incubation with Leishmania amastigotes because
both pathogens use the cell surface molecule DC-SIGN as a portal
of entry in these professional antigen-presenting cells [18]. In the
present work, we show that an initial pulsing of DCs with HIV-1
followed by exposure to the amastigote form of the parasite leads
to an increased HIV-1 replication in both DCs and CD4
+ T cells
when these two cell subtypes are cocultured together. Interestingly,
the promastigote developmental stage of the parasite does not
affect virus production under similar experimental procedures.
Previous studies have concluded that numerous glycoconjugates
that are differentially expressed on the cell surface of the parasite
in its promastigote stage (e.g. lipophosphoglycan, leishmanolysin/
gp63, low molecular weight glycoinositolphospholipids and a
membrane proteophosphoglycan) could be involved in the binding
of parasites to target cells [34], but we can conclude that these
promastigote-specific molecules have no direct role in the parasite-
mediated effect on HIV-1 biology in the DC/CD4
+ T cell milieu.
Moreover, our results are in agreement with other studies showing
that amastigotes are internalized by DCs more efficiently than
promastigotes [18,32,33], therefore validating the hypothesis that
engulfment of Leishmania parasites is controlled by several factors,
such as DC subtypes, Leishmania species and parasite stages
[16,17,35].
It is now well established that DCs can efficiently transmit HIV-
1 to neighbouring CD4
+ T cells through both trans- and cis-
infection pathways. Trans-infection mediated by DCs can occur
across infectious synapses [8,9,11] and via exocytosis of virus-
associated exosomes [36], whereas the cis-infection route relies on
de novo virus infection of DCs and long-term transmission of HIV-1
[7,9,37,38]. It is conceivable that both of these mechanisms may
coexist and contribute to viral dissemination. In our experimental
model, we provide evidence that Leishmania amastigotes are
affecting HIV-1 replication at different levels in a coculture
system consisting of DCs (either iDCs or mDCs) and autologous
CD4
+ T cells. Indeed, we demonstrate that the parasite increases
virus production in both DCs and CD4
+ T cells when these two
cell types are cocultured together. Moreover, we report that the
percentage of CD4
+ T cells productively infected by HIV-1 does
not seem to be affected by Leishmania amastigotes at an early time
point after the initiation of the coculture (i.e. 3 days). It can be
proposed that the parasite is not modulating the viral transfer
process between DCs and CD4
+ T cells but is instead positively
regulating virus gene expression in each cell type. Interestingly,
our data indicate that a close contact between Leishmania-pulsed
DCs and CD4
+ T cells is not mandatory to stimulate HIV-1
production, therefore suggesting that the observed increase in virus
replication is achieved through the secretion of a soluble factor (s).
Elevated plasma protein levels of proinflammatory cytokines
and chemokines such as IL-1, IL-6 and TNF-a have been detected
in VL patients [39]. Based on this information, it can be proposed
that Leishmania may modulate HIV-1 replication in our experi-
mental coculture cell system by promoting secretion of proin-
flammatory cytokines known to amplify virus gene expression.
This hypothesis was corroborated by a multiplex fluorescent
microfluid immunoassay, which revealed that exposure of DCs to
Leishmania amastigotes increases secretion of IL-6 and TNF-a.
Coculture studies carried out in the presence of neutralizing
antibodies specific for IL-6 or TNF-a showed that these two
cytokines have a major role in the observed Leishmania-induced
increase in HIV-1 replication in cocultured cells. A previous study
has shown that lipophosphoglycan, a major surface molecule of
Leishmania, acts as an effective activator of HIV-1 expression in a T
lymphoid cell line latently infected with HIV-1 through secretion
of TNF-a [40]. It is of interest to note that TNF-a seems to be
Figure 6. Leishmania infantum amastigotes promote secretion of
IL-6 and TNF-a. iDCs were either left unexposed (Control) or exposed
to Leishmania infantum amastigotes (Li) for 24 h. Cell-free supernatants
were collected and analyzed with a Bio-Plex assay. The results shown
are representative of five separate experiments performed with
different donors. Asterisks denote statistically significant differences
from the uninfected cells (P,0.05; **, P,0.01).
doi:10.1371/journal.pntd.0000441.g006
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growth [41]. For example, anti-TNF-a treatment resulted in the
reactivation of VL in patients being treated for arthritis, suggesting
a protective role of TNF-a against Leishmania infection [42]. On
the other hand, when produced at very high levels, TNF-a might
have a disease-enhancing effect. For example, one study identified
a link between VL and an allelic polymorphism associated with
elevated serum levels of TNF-a [43]. High levels of TNF-a
promote the generation of IL-10-producing T cells as a
homeostatic response to excessive inflammation [44]. It is also
Figure 7. Parasite-mediated enhancement of virus replication in cocultured cells is due to IL-6 and TNF-a. First, iDCs were pulsed for
60 min with NL4-3Balenv and either left unexposed or exposed to Leishmania infantum amastigotes (Li). Next, iDCs were cocultured with autologous
CD4
+ T cells (A) or cultured alone (B) and either left untreated or treated with the listed reagents (IL-6, 10 U/ml; anti-IL-6, 10 mg/ml; isotype-matched
control antibody, 10 mg/ml; TNF-a, 10 ng/ml; anti-TNF-a, 500 ng/ml; and PTX, 100 mM). Virus production was estimated by measuring p24 levels in
the culture supernatants either at 4 days following initiation of the coculture (A) or at 6 days post-infection (B). The results shown are representative
of four separate experiments performed with different donors and are expressed as relative viral production compared to untreated iDCs. Asterisks
denote statistically significant data (*, P,0.05; **, P,0.01).
doi:10.1371/journal.pntd.0000441.g007
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tion in cells of the macrophage lineage through nuclear
translocation of NF-kB [19,45,46]. Infection of monocyte-derived
macrophages (MDMs) with HIV-1 also induces TNF-a secretion
resulting in a positive autocrine loop that enhances virus
production [47]. Thus, it can be suggested that the Leishmania-
mediated release of TNF-a by DCs may function in an autocrine/
paracrine manner to induce virus gene expression in cells
harboring HIV-1. The same applies to IL-6 as it has been
reported to augment HIV-1 replication in MDMs as well as in the
latently infected U1 monocytoid cell line. Furthermore, IL-6 has
been shown to potentiate TNF-a-induced upregulation of HIV-1
production and induction of NF-kB [21,22].
Previous studies have shown that PTX, as an effective inhibitor
of protein kinase C, protein kinase A and NF-kB, selectively
inhibits TNF-a production, as well as HIV-1 transcription and
virus production [48,49]. We show in our study that the parasite-
dependent enhancement in HIV-1 production in cocultured cells
is no longer seen in presence of PTX. Our observations are in line
with a previous report describing that PTX, a methylxanthine
derivative that inhibits TNF-a synthesis, diminishes plasma viral
load and improves cell-mediated immunity in HIV-1-infected
individuals [50]. There is a possibility that PTX might also
negatively affect NF-kB signaling in addition to TNF-a produc-
tion, which could in turn reduce virus gene expression. However,
the contribution of TNF-a in the parasite-dependent augmenta-
tion of virus production in cocultured cells is confirmed when
using blocking anti-TNF-a antibodies. Results presented herein
thus show that Leishmania amastigotes alter the complex cellular
cytokine network and promote secretion of the proinflammatory
cytokines IL-6 and TNF-a. Although our data suggest a major role
for IL-6 and TNF-a in the Leishmania-induced effect on HIV-1
replication in a coculture system constituted of DCs and CD4
+ T
cells, we cannot eliminate the possibility that other soluble factors
are involved, either upstream or downstream from them.
HIV-1 and Leishmania are the cause of a vast array of
immunological disorders. Both infections alter the predominant
cellular immune response through complex cytokine-mediated
mechanisms that confer susceptibility to both infections. DCs are
proposed to have a dominant role in the early events of HIV-1
transmission by transporting the virus from peripheral sites to
lymphoid compartments. Moreover, DCs act also as a natural and
stable cellular reservoir in the natural course of Leishmania
infection. The present study illustrates that the effect of Leishmania
on HIV-1 replication in a coculture system composed of DCs and
CD4
+ T cells largely depends on the developmental stage of the
parasite and the chronology of infection of DCs by the two
pathogens. We demonstrate that Leishmania amastigotes enhance
the process of HIV-1 replication by favouring a higher production
of the proinflammatory cytokines IL-6 and TNF-a. Data from the
current study lead us to speculate about the putative role played by
Leishmania in the context of a co-infection with HIV-1. The various
immunological disturbances caused by Leishmania in DCs, a cell
population recognized as both a virus and parasite reservoir, can
be considered as detrimental to the host by promoting HIV-1
replication and progression of the disease. This assumption is
validated by clinical studies showing that leishmaniasis enhances
the viral load and reduces life expectancy in HIV-1-infected
patients [51–53].
In conclusion, this analysis provides novel insights into the
complex interconnections between HIV-1 and Leishmania and
presents unique information that may facilitate the development of
more effective therapeutic strategies aimed at controlling disease
progression in dually infected individuals.
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